Take a look at our previous reports:

11. Income taxes

The following table summarizes the income taxes recognized in profit or loss for the years ended 31 December 2023 and 2022.

 

Year ended 31 December

(thousands of €)

2023

2022(*)

Current tax

(5,928)

(1,738)

Deferred tax

(3,685)

1,166

Total income taxes

(9,613)

(572)

(*)

The 2022 comparative has been restated to reflect the impact of classifying the Jyseleca® business as discontinued operations in 2023.

Current tax, consisting of corporate income taxes, and deferred tax income/cost (–) related to subsidiaries of our continuing operations working on a cost plus basis. The increase in 2023 as compared to 2022 was primarily due to the re-assessment of net deferred tax liabilities and corporate income tax payables as a result of a one-off intercompany transaction. 

Taxes recognized in profit or loss

For the purpose of the disclosure below corporate tax was calculated at 25% (2022: 25%) – which is the tax rate applied in Belgium – on the estimated assessable profit for the year. The applied tax rate for other territorial jurisdictions was the tax rate that is applicable in these respective territorial jurisdictions on the estimated taxable result of the accounting year.

 

Year ended 31 December

(thousands of €)

2023

2022(*)

Profit /loss (-) before taxes

5,625

(70,849)

Income tax debit/credit (-), calculated using the Belgian statutory tax rate on the accounting profit/loss (-) before tax (theoretical)

1,406

(17,712)

Tax expenses in income statement (effective)

9,613

572

Difference in tax expenses/income to explain

8,207

18,284

 

 

 

Effect of tax rates in other jurisdictions

(94)

(337)

Effect of non-taxable income

(6,752)

(5,828)

Effect of share-based payment expenses without tax impact

9,157

15,501

Effect of expenses/income (-) not subject to tax

(5)

(146)

Effect of non-tax-deductible expenses

1,549

2,975

Effect of recognition of previously non recognized deferred tax assets

(81)

(1,677)

Effect of tax losses (utilized) reversed

(267)

-

Effect from under or over provisions in prior periods

(722)

1,101

Effect of non-recognition of deferred tax assets

34,339

4,819

Effect of derecognition of previously recognized deferred tax assets

1,062

1,877

Effect of use of IID

(29,979)

-

Total explanations

8,207

18,284

(*)

The 2022 comparative has been restated to reflect the impact of classifying the Jyseleca® business as discontinued operations in 2023.

Non-taxable income for the years ended 31 December 2023 and 2022 were related to non-taxable grants and tax credits.